alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2545 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
117th CONGRESS
  1st Session
                                H. R. 2545

_______________________________________________________________________

                                 AN ACT

 
 To amend title 38, United States Code, to clarify the role of doctors 
 of podiatric medicine in the Department of Veterans Affairs, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ROLE OF DOCTORS OF PODIATRIC MEDICINE IN DEPARTMENT OF 
              VETERANS AFFAIRS.

    (a) Clarification of Role.--Section 7306 of title 38, United States 
Code, is amended--
            (1) in subsection (a)--
                    (A) in paragraph (6), by striking ``a Director of 
                Podiatric Service,'';
                    (B) by redesignating paragraph (10) as paragraph 
                (11); and
                    (C) by inserting after paragraph (9) the following 
                new paragraph:
            ``(10) A Podiatric Medical Director, who shall be a 
        qualified doctor of podiatric medicine and who shall be 
        responsible to the Under Secretary for Health for the operation 
        of the Podiatric Service.'';
            (2) in subsection (b)(1), by inserting ``podiatric 
        medicine,'' after ``doctors of medicine,''; and
            (3) in subsection (c), by striking ``and (8)'' and 
        inserting ``(8), and (10)''.
    (b) Clarification of Pay Grade.--Section 7404 of title 38, United 
States Code, is amended--
            (1) in subsection (a)(2), by inserting ``, podiatrists,'' 
        after ``physicians'' ; and
            (2) in subsection (b), in the first heading of the list 
        following the colon, by striking ``PODIATRIST'' and inserting 
        ``PODIATRIST (DPM)''.

            Passed the House of Representatives June 15, 2021.

            Attest:

                                                                 Clerk.
117th CONGRESS

  1st Session

                               H. R. 2545

_______________________________________________________________________

                                 AN ACT

 To amend title 38, United States Code, to clarify the role of doctors 
 of podiatric medicine in the Department of Veterans Affairs, and for 
                            other purposes.
```
Resources of the National Credit Union Administration for Serving Underserved 

and “Unbanked” Customers 

Community Development Revolving Loan Fund Technical Assistance Grant Program: 

http://www.ncua.gov/letters/2005/CU/05-CU-05.pdf

Office of Small Credit Union Initiatives: http://www.ncua.gov/AboutNCUA/org/ocud.htm

Resource Connection: NCUA.gov/ResourceConnection

Reaching Underserved Populations: 

http://www.ncua.gov/CreditUnionDevelopment/UnderServed/underserved.html

Letter Regarding Individual Taxpayer Identification and Matricula Consular Numbers 

for Credit Reporting Purposes: 

http://www.ncua.gov/RegulationsOpinionsLaws/opinion_letters/2003_letters/03-

0964.htm
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 15**  **- 7817** 

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,
v. KIRK L. LONEY , Defendant

- Appellant
.

Appeal from the United States District Court for the Eastern District of Virginia , at Richmond
. Robert E. Payne , Senior District Judge. ( 3:02

- cr - 00290

- REP

- 1; 3:11

- cv - 00337

- REP )

Submitted : April 21, 2016 Decided: April 25, 2016

Before WILKINSON, KING, and KEENAN , Circuit Judges.

Affirmed by un published per curiam opinion
.
Kirk L. Loney, Appellant Pro Se. Michael Steven Dry, Stephen Wiley Miller, Assistant United States Attorneys, Michael Arlen Jagels, Special Assistant United States Attorney, Matthew Childs Ackley, OFFICE OF THE UNITED STATES ATTORNE Y, Richmond, Virginia, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Kirk L. Loney appeals from the district court’s order construing his Fed. R. Civ. P. 60(b) motion as an unauthorized successive 28 U.S.C . § 2255 (2012) motion and dismissing it on that basis. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. United States v. Loney , No s . 3:02

- cr - 000290

- REP

1 ; 3:11

- cv - 00337

- REP ( E.D. Va. Sept. 10, 2015). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before th is court and argument would not aid the decisional process.

AFFIRMED
**Exhibit 32(c)**

 

**The Dayton Power and LightCompany**

 

CERTIFICATION PURSUANT TO 18U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

 

Theundersigned officers of The Dayton Power and Light Company (the “Issuer”)hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that the Issuer’sQuarterly Report on Form 10-Q for the period ended March 31, 2008,which this certificate accompanies, fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 and that the informationcontained therein fairly presents, in all material respects, the financialcondition and results of operations of the Issuers as of the dates and for theperiods expressed therein.

 

Asigned original of this written statement required by Section 906 of theSarbanes-Oxley Act of 2002, or other document authenticating, acknowledging, orotherwise adopting the signature that appears in typed form within theelectronic version of this statement required by Section 906 of theSarbanes-Oxley Act of 2002, has been provided to the Issuer and will beretained by the Issuers and furnished to the Securities and Exchange Commissionor its staff upon request.

 

Signed:

 

 

 
| /s/ Paul M. Barbas                     |   |
|----------------------------------------|--------|
| Paul M. Barbas                         |   |
| President  and Chief Executive Officer |   |

 

Date:April 23, 2008

 

Theforegoing certificate is being furnished solely pursuant to 18 U.S.C. Section 1350and is not being filed as part of the Issuer’s Annual Report or as a separatedisclosure document.

 

54

----
#### SUMTER COUNTY, Florida, Appellant, v. H. E. DAVIS, Appellee.

No. 77-1408.

District Court of Appeal of Florida, Second District.

March 22, 1978.

Randall N. Thornton, Lake Panasoffkee, and Julian E. Harrison, Bushnell, for appellant.

No appearance for appellee.

OTT, Judge.

In this appeal the appellant complains of an order of the trial court denying its motion to dismiss the appellee’s complaint. We agree and therefore reverse.

The plaintiff/appellee filed a complaint for declaratory relief. After the necessary *900party identifications and jurisdictional allegations, the complaint charged that the appellant (Sumter County) had unlawfully enacted two zoning ordinances which were not in compliance with certain statutory formalities prescribed in Chapter 163, Florida Statutes (1976).

The only fact alleged in the complaint concerning the status of the appellee was that he “is the owner of certain real property located in the unincorporated area of Sumter County.” There is no suggestion anywhere in the complaint that any right of the appellee has been invaded or affected by the ordinance. The complaint is therefore lacking in an essential requirement for standing to secure declaratory relief, namely, “a right or need on the part of the complaining party to receive the declaration requested.” *Reid v. Kirk,*245 So.2d 877, 879 (Fla.1st DCA 1971). See *McNevin v. Baker,*170 So.2d 66 (Fla.2d DCA 1964).

In *Florida State Board of Dispensing Opticians v. Bayne,*204 So.2d 34, 37 (Fla.2d DCA 1967) the court held:

> In an action for declaratory relief, the complaining party must demonstrate that it has a judicially cognizable, bona fide, and direct interest in the result sought by the action.

In addition, the dispute must be justiciable in the sense that it be based upon some definite assertion of right. 9A Fla.Jur., Declaratory Actions § 13 (1972). In *Smith v. City of Pinellas Park,*336 So.2d 1255 (Fla.2d DCA 1976) the court held that plaintiffs had no standing to seek a declaratory judgment attacking the validity of an ordinance where no justiciable controversy existed. The court held that plaintiffs/appellants “have no real, immediate legal interest in such a declaration nor a present bona fide practical need therefor.” 336 So.2d at 1256. *Cf., Williams v. Howard,*329 So.2d 277 (Fla.1976).

Judge Pierce, writing for the majority in *Bayne,*held:

> The test of the sufficiency of a complaint for declaratory judgment is not whether the plaintiff will succeed in obtaining such a declaratory decree of rights in accordance with his theory, but whether he is entitled to a declaration of rights at all. 204 So.2d at 36.

Having failed to meet one of the essential requirements of standing to seek or secure declaratory relief the motion to dismiss the complaint should have been granted. The order of the trial court denying the motion to dismiss is therefore reversed and the cause remanded for further proceedings consistent herewith.

GRIMES, Acting C. J., and SCHEB, J., concur.
EXHIBIT 99.1


              CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63
                      OF TITLE 18 OF THE UNITED STATES CODE


     I, John L. Larsen, the Chief Executive Officer of Crested Corp., certify
that (i) the Quarterly Report on Form 10-Q for the period ended November 30,
2002 accompanying this statement, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of Crested Corp.

                                                   /s/  John L. Larsen
                                                 -------------------------------
                                                 John L. Larsen,
                                                 Chief Executive Officer

                                                 Date: January 13, 2003





              CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63
                      OF TITLE 18 OF THE UNITED STATES CODE


     I, Robert Scott Lorimer, the Chief Financial Officer of Crested Corp.,
certify that (i) the Quarterly Report on Form 10-Q for the period ended November
30, 2002 accompanying this statement, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of Crested Corp.

                                                   /s/  Robert Scott Lorimer
                                                 -------------------------------
                                                 Robert Scott Lorimer,
                                                 Chief Financial Officer

                                                 Date: January 13, 2003



<PAGE>
**Exhibit32**

 

THE DAYTON POWERAND LIGHT COMPANY

 

CERTIFICATIONPURSUANT TO SECTION 906

OF THESARBANES-OXLEY ACT OF 2002

 

The undersigned officersof The Dayton Power and Light Company (the “Issuer”) hereby certify that theIssuer’s Quarterly Report on Form 10-Q for the period ended June 30, 2004 whichthis certificate accompanies, fully complies with the requirements of Section13(a) or 15(d) of the Securities Exchange Act of 1934 and that the informationcontained in the Form 10-Q fairly presents, in all material respects, thefinancial condition and results of operations of the Issuer.

 

A signed original of thiswritten statement required by Section 906 has been provided to the Issuer andwill be retained by the Issuer and furnished to the Securities and ExchangeCommission or its staff upon request.

 

Signed:

 

 
| /s/ James V. Mahoney         |   |
|------------------------------|--------|
| James V. Mahoney             |
|                         |
|                         |
| /s/ Pamela Holdren           |   |
| Pamela Holdren               |
|                         |
|                         |
| Date:  November 5, 2004 |

 

----
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7030 Introduced in House (IH)]

<DOC>

116th CONGRESS
  2d Session
                                H. R. 7030

 To provide emergency assistance to covered producers for market-ready 
   swine losses due to the COVID-19 pandemic, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 27, 2020

Mr. Hagedorn (for himself and Mr. Emmer) introduced the following bill; 
           which was referred to the Committee on Agriculture

_______________________________________________________________________

                                 A BILL

 
 To provide emergency assistance to covered producers for market-ready 
   swine losses due to the COVID-19 pandemic, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EMERGENCY ASSISTANCE FOR MARKET-READY SWINE LOSSES.

    (a) In General.--Of the funds of the Commodity Credit Corporation, 
the Secretary shall use $1,200,000,000 to provide emergency relief to 
covered producers to aid in the reduction of intentional depopulation 
losses of swine due to the closure or the reduction in processing 
capacity of a processing plant related to the COVID-19 pandemic.
    (b) Valuation.--In determining the amount of losses for purposes of 
the payment rates under subsection (a), the Secretary shall use the 
average sales price, as determined by the Secretary in collaboration 
with the Chief Economist of the Department of Agriculture and the 
Administrator of the Agricultural Marketing Service, for market-ready 
swine on April 19, 2020. In no case shall the payment made under 
subsection (a) with respect to the losses of a covered producer exceed 
the actual market value of market-ready livestock on the day on which 
the covered producer began to suffer such losses.
    (c) Eligible Losses.--A covered producer shall be eligible for 
losses described in subsection (a) incurred on or after April 19, 2020.
    (d) Definitions.--In this section:
            (1) Covered producer.--The term ``covered producer'' means 
        a person or legal entity that assumes the production and market 
        risks associated with the agricultural production of swine (as 
        such terms are defined in section 2(a) of the Packers and 
        Stockyards Act, 1921 (7 U.S.C. 183(a))).
            (2) Secretary.--The term ``Secretary'' means the Secretary 
        of Agriculture.
                                 <all>
```
Document

CERTAIN IDENTIFIED INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY “[***]”, HAS BEEN EXCLUDED BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) THE TYPE THAT SURFACE ONCOLOGY, INC. TREATS AS PRIVATE OR CONFIDENTIAL.

                Exhibit 10.2


AMENDMENT NO. 1 TO LICENSE AGREEMENT


This Amendment No. 1 (“Amendment No. 1”) to the License Agreement dated December 20, 2020 between GlaxoSmithKline Intellectual Property (No. 4) Limited, having a principal place of business at 980 Great West Road, Brentford, Middlesex TW8 9GS United Kingdom (“GSK”) and Surface Oncology, Inc., having a place of business at 50 Hampshire Street, Cambridge MA 02139 (“Surface”) is effective as of August 11, 2021 (“Amendment Effective Date”). Each of GSK and Surface may be referred to herein as a “Party” and together, the “Parties”.


RECITALS


WHEREAS, GSK and Surface desire to amend the Transition Plan as set forth on Exhibit C hereto, in accordance with Section 15.6.


NOW THEREFORE, in consideration of the premises and the mutual promises and conditions hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby agree as follows:
1.Definitions. Capitalized terms used but not defined herein shall have the meaning set forth in the Agreement.


2.Transition Plan. The Parties agree to amend the Transition Plan as attached hereto as Exhibit C in order to permit Surface to order [***] of Licensed Product from the Existing CMO for transfer to GSK, as described in more detail in the Transition Plan. The Transition Plan sets forth the additional Transition Costs to be reimbursed to Surface by GSK in connection with the Manufacture of [***] of Licensed Product in accordance with Section 3.4 of the Agreement. Further, the Parties acknowledge and agree that [***] in accordance with the Transition Plan.


IN WITNESS WHEREOF, each Party has caused this Amendment No. 1 to be duly executed by its authorized representative on the Amendment Effective Date.


						
	SURFACE ONCOLOGY, INC.


/s/ Robert Ross
Name: Robert Ross, MD
Title: President and CEO


/s/ Jessica Fees
Name:  Jessica Fees
Title:  Chief Financial Officer
	GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO. 4 LIMITED
 /s/ John Sadler
NAME: JOHN SADLER
AUTHORISED SIGNATORY
 FOR AND ON BEHALF OF
THE WELLCOME FOUNDATION LIMITED
 CORPORATE DIRECTOR
/s/ Claire MacLeod
NAME: CLAIRE MACLEOD
AUTHORISED SIGNATORY
 FOR AND ON BEHALF OF
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED 
CORPORATE DIRECTOR



                
                               DATE: 18TH AUGUST 2021






			
	ACTIVE/113088899.2 












EXHIBIT C TRANSITION PLAN
[***]
			
	ACTIVE/113088899.2
Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of DE Acquisition 2, Inc. (the "Company") on Form 10-K for the fiscal year ended February 28, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Dennis Nguyen, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Dennis Nguyen

Dennis Nguyen

Principal Financial Officer

May 31, 2011
#### Mary D. LEGGE, Petitioner, v. ALBERT A. LEGGE LAND CO., INC., a Florida corporation, et al., Respondents.

No. 43916.

Supreme Court of Florida.

Oct. 12, 1973.

Certiorari denied. 276 So.2d 208.

CARLTON, C. J., and ROBERTS, ERVIN, ADKINS and DEKLE, JJ., concur.
##### 



Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of ML Life Insurance Company of New York
(the Company) on Form 10-K for the period ended
December 31, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the Report),
I, Joseph E. Justice, Senior Vice President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) |  | The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
| | --- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (2) |  | The information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company.



| | /s/ JOSEPH E. JUSTICE
Joseph E. Justice
Senior Vice President and
Chief Financial Officer
| | -----------------------------------------------------------------------------------------

Dated:
March 27, 2006

A signed original of this written statement required by Section 906 has been
provided to ML Life Insurance Company of New York and will be retained by ML
Life Insurance Company of New York and furnished to the Securities and Exchange
Commission or its staff upon request.
<PAGE> 30

                                                                  Exhibit 12


        AMERICAN GENERAL FINANCE CORPORATION AND SUBSIDIARIES
          Computation of Ratio of Earnings to Fixed Charges
                             (Unaudited)




                                                        Three Months Ended
                                                             March 31,
                                                        2005          2004
                                                      (dollars in thousands)

Earnings:
  Income before provision for income
    taxes                                             $187,239      $159,920
  Interest expense                                     192,829       135,556
  Implicit interest in rents                             4,588         4,717

Total earnings                                        $384,656      $300,193


Fixed charges:
  Interest expense                                    $192,829      $135,556
  Implicit interest in rents                             4,588         4,717

Total fixed charges                                   $197,417      $140,273


Ratio of earnings to fixed charges                        1.95          2.14
Exhibit 10.2


  


	Ryan Pratt





Guerrilla RF





1196 Pleasant Ridge Rd ., Suite 5








Greensboro, NC 27409


June 14, 2019



	 






 


Mark Mason


[Address]





Kernersville, NC [zip]


 


Dear Mark Mason:


 


It is our pleasure to
confirm our offer of employment to you as Chief Operations Officer at Guerrilla RF. In this position, you will report directly to
Ryan Pratt beginning Monday July 22nd, 2019.





 


Your salary will be $201,600.00 per
year with paychecks issued bi-weekly. In addition to milestone adjustments, you will receive consideration on your hiring date anniversary
for normal pay cycle salary increases.


 


Upon starting
your employment, you will be granted 50,000 Common Stock Option Shares. If you leave Guerrilla RF before one year of continuous employment,
the option shares will revert to the company. After one year, your options will vest at a rate of 25% per year employed.


 


You will be eligible
for medical, dental, vision, disability, and basic life insurance benefits beginning on your first day of employment, most of which are
available to employees for no cost. Guerrilla RF offers a generous Paid-Time-Off (PTO) policy with quarterly company holidays/shutdowns.


 


To confirm your acceptance of this offer of
employment, please sign below and return to me by scan/e-mail at rpratt@guerrilla-rf.com.


 


	 	 	6/17/2019
	Signature	 	Date



 


Sincerely,


 


	/s/ Ryan Pratt	 
	Ryan Pratt	 
	Founder, CEO
Exhibit 31.3

CERTIFICATIONS

I, Sudhir Agrawal, certify that:

1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Idera Pharmaceuticals, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.



/s/ SUDHIR AGRAWALSudhir AgrawalChairman, President and Chief Executive Officer


Date: April 30, 2013